Healthcare · Drug Manufacturers—Specialty & Generic
$8.85
+$0.18+2.08%
Delayed · · marketstack
2 open-market sales on file ($1.65M), none of them under a pre-arranged plan. Who, and when
+$0.42+4.98%over 1M
Session
Day range85% of range
$8.68$8.88
Fundamentals
Visualize fundamentals and more- Market cap
- 516.36M
- P/E ratio
- 25.56
Price ÷ trailing earnings
Against its own history it is 14.82% more expensive than usual. Its median P/E over 4 filed years is 22.3.
Revenue grew +12.12% in FY2025, +3.25% faster than its sector. The median across Healthcare companies this platform tracks is +8.87%.
Discussion
No comments yet
Set a username to join the discussion. It’s the only thing shown next to what you post, never your email address.
Comments are written by other users. Nothing here is investment advice and nothing is checked for accuracy.
Updated · the last close
Kamada Ltd investor relations
What KMDA has filed with the SEC. This is not Kamada Ltd’s own investor relations site: these filings are the primary source that site publishes from.
Companies like Kamada Ltd
Also filed under Drug Manufacturers, ranked by how closely they sit beside KMDA.
- LLYELI LILLY & Cocompare with KMDA
- JNJJohnson & Johnsoncompare with KMDA
- AMGNAmgen Inc.compare with KMDA